Signaling Pathways
-
B5857 SBE 13 HClTarget: PLKSummary: Inactive Plk1 inhibitor -
B5858 ITD 1Summary: The first selective TGFβ inhibitor -
B5859 EntrectinibTarget: Trk Receptors|ALK|ROS1Summary: Orally active inhibitor of ALK kinase -
B5860 TAK960Target: PLKSummary: Oral and selective PLK1 inhibitor -
B5861 Molidustat (BAY85-3934)Target: HIF-PHSummary: Novel HIF-PH inhibitor -
B5863 LX7101 HCLSummary: Dual LIM-kinase and ROCK inhibitor -
B5864 Fruquintinib(HMPL-013)Target: VEGFRSummary: Potent and selective inhibitor of VEGFR 1, 2, 3 -
B5868 MK3102Summary: Novel long-acting DPP-4 inhibitor -
B5870 ELR510444Summary: Novel microtubule disruptor -
B5872 RQ-00203078Summary: Selective and orally active TRPM8 antagonist

